首页> 中文期刊> 《中华医学杂志(英文版)》 >Impact of Libido at 2 Weeks after Stroke on Risk of Stroke Recurrence at 1-Year in a Chinese Stroke Cohort Study

Impact of Libido at 2 Weeks after Stroke on Risk of Stroke Recurrence at 1-Year in a Chinese Stroke Cohort Study

         

摘要

Background:There were few studies on the relation between changes in libido and incidence of stroke recurrence.The aim of this study was to investigate the relationship between libido decrease at 2 weeks after stroke and recurrent stroke at 1-year.Methods:It is a multi-centered,prospective cohort study.The 14th item of the Hamilton Depression Rating Scale-17 was used to evaluate changes of libido in poststroke patients at 2 weeks.Stroke recurrence was defined as an aggravation of former neurological functional deficit,new local or overall symptoms,or stroke diagnosed at re-admission.Results:Among 2341 enrolled patients,1757 patients had completed follow-up data,533 (30.34%) patients had decreased libido at 2 weeks,and 166 (9.45%) patients had recurrent stroke at 1-year.Multivariate logistic regression analysis showed that,compared with patients with normal libido,the odds ratio (OR) of recurrent stroke in patients with decreased libido was reduced by 41% (OR =0.59,95% confidence interval [CI]:0.40-0.87).The correlation was more prominent among male patients (OR =0.52,95% CI:0.31-0.85) and patients of≥60 years of age (OR =0.57,95% CI:0.35-0.93).Conclusions:One out of three stroke patients in mainland China has decreased libido at 2 weeks after stroke.Decreased libido is a protective factor for stroke recurrence at 1-year,which is more prominent among older male patients.

著录项

  • 来源
    《中华医学杂志(英文版)》 |2015年第10期|1288-1292|共5页
  • 作者单位

    Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,China National Clinical Research Center for Neurological Diseases,Center of Stroke,Beijing Institute for Brain Disorders,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease,Beijing 100050,China;

    Department of Neurology,The First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang 310003,China;

    Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,China National Clinical Research Center for Neurological Diseases,Center of Stroke,Beijing Institute for Brain Disorders,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease,Beijing 100050,China;

    Department of Neuropsychiatry and Behavioral Neurology and Clinical Psychology,Beijing Tiantan Hospital,Capital Medical University,Beijing 100050,China;

    Department of Neurology,The First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang 310003,China;

    Department of Neurology,The First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang 310003,China;

    Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,China National Clinical Research Center for Neurological Diseases,Center of Stroke,Beijing Institute for Brain Disorders,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease,Beijing 100050,China;

    Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,China National Clinical Research Center for Neurological Diseases,Center of Stroke,Beijing Institute for Brain Disorders,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease,Beijing 100050,China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号